血液腫瘍検査の世界市場規模調査・予測：製品・サービス別、がんタイプ別（白血病、非ホジキンリンパ腫）、技術別、エンドユーザー別、地域別分析、2022-2029年

ヘマト・オンコロジー検査は血液疾患の診断・治療・予防であり、オンコロジーはがんの治療です。

血液腫瘍学には、血友病、鉄欠乏性貧血、白血病とリンパ腫、鎌状赤血球症、サラセミア、その他の臓器がんが含まれます。血液腫瘍検査市場は、血液がんの罹患率の上昇や個別化治療の需要増加などの要因から拡大しています。

2018年のPMC PubMed Centralによると、2018年に米国全体で約174,250人が同系悪性腫瘍と診断されたとのことです。また、約129万人がHMと共存しており、発症率は上昇傾向にあります。2020年の米国臨床腫瘍学会によると、2020年の推定がん数は、男性679,412人よりも女性712,758人ほど多くなっています。一方、血液腫瘍診断のための高度な分子技術や、薬剤と診断薬の共同開発の増加が、市場に有利な機会を生み出しています。しかし、不利な償還シナリオは、2022年から2029年の予測期間を通じて市場成長の妨げとなります。

世界の血液腫瘍検査市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、その他の世界地域です。北米は、血液がんの有病率の増加、高齢化社会の進展、高度な治療法の認知度などにより、収益面で市場を独占しています。一方、北米は、白血病、リンパ腫、多発性骨髄腫の有病率の増加、予測期間中の市場関係者による研究開発活動の増加などの要因から、予測期間中に大きく成長すると予想されます。

本調査の目的は、近年における様々なセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• 市場スナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • ヘマトオンコロジーテスティング市場：地域別、2019-2029年
  • ヘマトオンコロジーテスティング市場：製品・サービス別、2019年～2029年
  • ヘマトオンコロジーテスティング市場：がんタイプ別、2019-2029年
  • ヘマトオンコロジーテスティング市場：技術別、2019-2029年
  • ヘマトオンコロジー検査市場：エンドユーザー別、2019年～2029年
• 主な動向
• 調査手法
• 調査前提条件

第2章 ヘマトオンコロジー検査の世界市場の定義と範囲

• 調査の目的
• 市場の定義と範囲
  • 本調査の対象範囲
  • 産業の進化
• 調査対象年
• 通貨換算レート

第3章 ヘマトオンコロジーテストの世界市場力学

• ヘマトオンコロジーテスティング市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 血液がんの罹患率の上昇
    • 個別化治療に対する需要の増加
  • 市場の課題
    • 不利な償還シナリオ
  • 市場機会
    • 血液腫瘍診断のための先進的な分子技術の台頭
    • 医薬品と診断薬の共同開発の増加

第4章 世界の血液腫瘍検査市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
• 投資採用モデル
• アナリストの結論・提言
• トップ投資機会
• 主要成功戦略

第5章 リスクアセスメントCOVID-19のインパクト

• COVID-19が業界に与える全体的な影響の評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 血液腫瘍学検査の世界市場、製品・サービス別。

• 市場スナップショット
• 血液腫瘍検査の世界市場：製品・サービス別、実績-ポテンシャル分析
• 血液腫瘍検査の世界市場、製品・サービス別推定・予測、2019-2029年
• 血液腫瘍検査の市場、サブセグメント分析
  • アッセイキット
  • サービス

第7章：血液腫瘍検査の世界市場：がんタイプ別

• 市場スナップショット
• 血液腫瘍検査の世界市場：がんタイプ別、パフォーマンス-ポテンシャル分析
• 血液腫瘍学検査の世界市場、がんタイプ別推定・予測2019～2029年
• 血液腫瘍学検査市場、サブセグメント分析
  • 白血病
  • 非ホジキンリンパ腫

第8章 血液腫瘍学検査の世界市場、技術別。

• 市場スナップショット
• 血液腫瘍検査の世界市場：技術別、実績-ポテンシャル分析
• ヘマトオンコロジー検査の世界市場、技術別推定・予測、2019-2029年
• 血液腫瘍検査の市場、サブセグメント分析
  • PCR、ポリメラーゼ連鎖反応
  • NGS,次世代シーケンサー（NGS）
  • IHC免疫組織化学（IHC）

第9章 血液腫瘍学検査の世界市場：エンドユーザー別

• 市場スナップショット
• 血液腫瘍検査の世界市場：エンドユーザー別、性能-ポテンシャル分析
• 血液腫瘍検査の世界市場、エンドユーザー別推定・予測2019-2029
• 血液腫瘍学検査市場、サブセグメント分析
  • クリニカル・ラボラトリーズ
  • 病院

第10章 ヘマトオンコロジーテストの世界市場：地域別分析

• 血液腫瘍検査市場、地域別市場スナップショット
• 北米
  • 米国
    • 製品・サービス別の推定・予測、2019年～2029年
    • がんタイプ別の推定・予測、2019年～2029年
    • 技術別の推定・予測（2019年-2029年
    • エンドユーザー別の推定・予測、2019年～2029年
  • カナダ
• 欧州ヘマトオンコロジー検査市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州地域
• アジア太平洋地域の血液腫瘍検査市場のスナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの血液腫瘍検査市場のスナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第11章 競合情報

• トップ市場戦略
• 企業プロファイル
  • F. Hoffmann-La Roche Ltd
    • 主要情報
    • 概要
    • 財務情報（データの入手状況により異なります）
    • 製品概要
    • 最近の動向
  • Abbott
  • Invitae Corporation（Archerdx, Inc）
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories, Inc.-
  • Molecularmd（Subsidiary of Icon PLC）
  • Asuragen, Inc.
  • Arup Laboratories Inc.

第12章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査属性
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Hemato Oncology Testing Market, report scope
• TABLE 2. Global Hemato Oncology Testing Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Hemato Oncology Testing Market estimates & forecasts by Product & Services 2019-2029 (USD Billion)
• TABLE 4. Global Hemato Oncology Testing Market estimates & forecasts by Cancer Type 2019-2029 (USD Billion)
• TABLE 5. Global Hemato Oncology Testing Market estimates & forecasts by Technology 2019-2029 (USD Billion)
• TABLE 6. Global Hemato Oncology Testing Market estimates & forecasts by End-User 2019-2029 (USD Billion)
• TABLE 7. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Hemato Oncology Testing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. Global Hemato Oncology Testing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. U.S. Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. U.S. Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. Canada Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. Canada Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. UK Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. UK Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. Germany Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. Germany Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. France Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. France Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Italy Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Italy Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. Spain Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. Spain Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. RoE Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. RoE Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. China Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. China Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. India Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. India Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. Japan Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. Japan Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. South Korea Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. South Korea Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. Australia Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. Australia Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. RoAPAC Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. RoAPAC Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Brazil Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Brazil Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. Mexico Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. Mexico Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. RoLA Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. RoLA Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Hemato Oncology Testing Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 69. Row Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 70. Row Hemato Oncology Testing Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 71. List of secondary sources, used in the study of global Hemato Oncology Testing Market
• TABLE 72. List of primary sources, used in the study of global Hemato Oncology Testing Market
• TABLE 73. Years considered for the study
• TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Hemato Oncology Testing Market, research methodology
• FIG 2. Global Hemato Oncology Testing Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Hemato Oncology Testing Market, key trends 2021
• FIG 5. Global Hemato Oncology Testing Market, growth prospects 2022-2029
• FIG 6. Global Hemato Oncology Testing Market, porters 5 force model
• FIG 7. Global Hemato Oncology Testing Market, pest analysis
• FIG 8. Global Hemato Oncology Testing Market, value chain analysis
• FIG 9. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Hemato Oncology Testing Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Hemato Oncology Testing Market, regional snapshot 2019 & 2029
• FIG 15. North America Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Hemato Oncology Testing Market 2019 & 2029 (USD Billion)
• FIG 19. Global Hemato Oncology Testing Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Hemato Oncology Testing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Hemato Oncology Testing is the diagnosis, treatment, and prevention of blood diseases, while oncology is the treatment of cancer. Hematology-oncology encompasses hemophilia, iron deficiency anaemia, leukemias and lymphomas, sickle cell disease, thalassemia's, and other organ cancers. The Hemato Oncology Testing market is expanding because of factors such as the rising incidences of hematologic cancer and increasing demand for personalized therapy.

According to the PMC PubMed Central in 2018, around 174,250 people across the United States in 2018 were diagnosed with homological malignancies. Also, the incidences are rising about 1.29 million people are living with HM's. According to the American Society of Clinical Oncology in 2020, the estimated number of cancers is higher in females with around 712,758 than in males with 679,412 in 2020. Whereas advanced molecular techniques for hemato-oncology diagnostics and increasing drug-diagnostic co-development create lucrative opportunities for the market. However, unfavorable reimbursement scenario hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Hemato Oncology Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing prevalence of hematologic cancer, growing aging population, and awareness of advanced treatment methods. Whereas, North America is expected to grow significantly during the forecast period, owing to factors such as growing prevalence of leukemia, lymphoma, and multiple myeloma diseases, growing R&D activities by market players in the forecast period

Major market players included in this report are:

F. Hoffmann-La Roche Ltd

Abbott

Invitae Corporation (Archerdx, Inc)

QIAGEN

Thermo Fisher Scientific Inc.

Illumina Inc.

Bio-Rad Laboratories, Inc.-

Molecularmd (Subsidiary of Icon PLC)

Asuragen, Inc.

Arup Laboratories Inc.

Recent Developments in the Market:

• In May 2018, Adaptive Biotechnologies (US) and Sanofi, SA. (US) collaborated to use Adaptive's clonoSEQ Assay to assess MRD status in response to isatuximab.
• In July 2018, Abbott Laboratories (US) received FDA approval for its Abbott RealTime IDH1 kit

Global Hemato Oncology Testing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product & Service, Cancer Type, Technology, End User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Service:

Assay Kits

Services

By Cancer:

Leukemia

Non-Hodgkin's Lymphoma

By Technology:

PCR, Polymerase chain reaction

NGS, Next-generation sequencing (NGS)

IHC Immunohistochemistry (IHC)

By End-User:

Clinical Laboratories,

Hospitals

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Hemato Oncology Testing Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Hemato Oncology Testing Market, by Product & Service, 2019-2029 (USD Billion)
  • 1.2.3. Hemato Oncology Testing Market, by Cancer Type, 2019-2029 (USD Billion)
  • 1.2.4. Hemato Oncology Testing Market, by Technology, 2019-2029 (USD Billion)
  • 1.2.5. Hemato Oncology Testing Market, by End-User, 2019-2029 (USD Billion)
  • 1.2.6.
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Hemato Oncology Testing Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Hemato Oncology Testing Market Dynamics

• 3.1. Hemato Oncology Testing Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising incidences of hematologic cancer
    • 3.1.1.2. Increasing demand for personalized therapy
  • 3.1.2. Market Challenges
    • 3.1.2.1. Unfavorable Reimbursement Scenario
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising advanced molecular techniques for hemato-oncology diagnostics
    • 3.1.3.2. Increasing drug-diagnostics co-development

Chapter 4. Global Hemato Oncology Testing Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre-COVID-19D-19 and post-COVID-19 Market scenario

Chapter 6. Global Hemato Oncology Testing Market, by Product & Service,

• 6.1. Market Snapshot
• 6.2. Global Hemato Oncology Testing Market by Product & Service, Performance - Potential Analysis
• 6.3. Global Hemato Oncology Testing Market Estimates & Forecasts by Product & Service, 2019-2029 (USD Billion)
• 6.4. Hemato Oncology Testing Market, Sub-Segment Analysis
  • 6.4.1. Assay Kits,
  • 6.4.2. Services

Chapter 7. Global Hemato Oncology Testing Market, by Cancer Type

• 7.1. Market Snapshot
• 7.2. Global Hemato Oncology Testing Market by Cancer Type, Performance - Potential Analysis
• 7.3. Global Hemato Oncology Testing Market Estimates & Forecasts by Cancer Type 2019-2029 (USD Billion)
• 7.4. Hemato Oncology Testing Market, Sub Segment Analysis
  • 7.4.1. Leukemia
  • 7.4.2. Non-Hodgkin's Lymphoma

Chapter 8. Global Hemato Oncology Testing Market, by Technology,

• 8.1. Market Snapshot
• 8.2. Global Hemato Oncology Testing Market by Technology, Performance - Potential Analysis
• 8.3. Global Hemato Oncology Testing Market Estimates & Forecasts by Technology, 2019-2029 (USD Billion)
• 8.4. Hemato Oncology Testing Market, Sub Segment Analysis
  • 8.4.1. PCR, Polymerase chain reaction
  • 8.4.2. NGS, Next-generation sequencing (NGS)
  • 8.4.3. IHC Immunohistochemistry (IHC)

Chapter 9. Global Hemato Oncology Testing Market, by End-User

• 9.1. Market Snapshot
• 9.2. Global Hemato Oncology Testing Market by End-User, Performance - Potential Analysis
• 9.3. Global Hemato Oncology Testing Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
• 9.4. Hemato Oncology Testing Market, Sub Segment Analysis
  • 9.4.1. Clinical Laboratories,
  • 9.4.2. Hospitals

Chapter 10. Global Hemato Oncology Testing Market, Regional Analysis

• 10.1. Hemato Oncology Testing Market, Regional Market Snapshot
• 10.2. North America Hemato Oncology Testing Market
  • 10.2.1. U.S. Hemato Oncology Testing Market
    • 10.2.1.1. Product & Services breakdown estimates & forecasts, 2019-2029
    • 10.2.1.2. Cancer Type breakdown estimates & forecasts, 2019-2029
    • 10.2.1.3. Technology breakdown estimates & forecasts, 2019-2029
    • 10.2.1.4. End-User breakdown estimates & forecasts, 2019-2029
  • 10.2.2. Canada Hemato Oncology Testing Market
• 10.3. Europe Hemato Oncology Testing Market Snapshot
  • 10.3.1. U.K. Hemato Oncology Testing Market
  • 10.3.2. Germany Hemato Oncology Testing Market
  • 10.3.3. France Hemato Oncology Testing Market
  • 10.3.4. Spain Hemato Oncology Testing Market
  • 10.3.5. Italy Hemato Oncology Testing Market
  • 10.3.6. Rest of Europe Hemato Oncology Testing Market
• 10.4. Asia-Pacific Hemato Oncology Testing Market Snapshot
  • 10.4.1. China Hemato Oncology Testing Market
  • 10.4.2. India Hemato Oncology Testing Market
  • 10.4.3. Japan Hemato Oncology Testing Market
  • 10.4.4. Australia Hemato Oncology Testing Market
  • 10.4.5. South Korea Hemato Oncology Testing Market
  • 10.4.6. Rest of Asia Pacific Hemato Oncology Testing Market
• 10.5. Latin America Hemato Oncology Testing Market Snapshot
  • 10.5.1. Brazil Hemato Oncology Testing Market
  • 10.5.2. Mexico Hemato Oncology Testing Market
• 10.6. Rest of The World Hemato Oncology Testing Market

Chapter 11. Competitive Intelligence

• 11.1. Top Market Strategies
• 11.2. Company Profiles
  • 11.2.1. F. Hoffmann-La Roche Ltd
    • 11.2.1.1. Key Information
    • 11.2.1.2. Overview
    • 11.2.1.3. Financial (Subject to Data Availability)
    • 11.2.1.4. Product Summary
    • 11.2.1.5. Recent Developments
  • 11.2.2. Abbott
  • 11.2.3. Invitae Corporation (Archerdx, Inc)
  • 11.2.4. QIAGEN
  • 11.2.5. Thermo Fisher Scientific Inc.
  • 11.2.6. Illumina Inc.
  • 11.2.7. Bio-Rad Laboratories, Inc.-
  • 11.2.8. Molecularmd (Subsidiary of Icon PLC)
  • 11.2.9. Asuragen, Inc.
  • 11.2.10. Arup Laboratories Inc.

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption